Aptevo Therapeutics annual gross profit
2015
2016
2017
2018
2019
Aptevo Therapeutics Gross Profit Growth & History (APVO)
Aptevo Therapeutics's gross profit was $12.5M for fiscal 2019.
View full Aptevo Therapeutics company overviewAptevo Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2019 | 2019-12-31 | $12.5M | $644,000 | +5.43% |
| 2018 | 2018-12-31 | $11.9M | $2.2M | +22.85% |
| 2017 | 2017-12-31 | $9.6M | $12.1M | — |
| 2016 | 2016-12-31 | −$2.5M | −$19.1M | — |
| 2015 | 2015-12-31 | $16.7M | — | — |
Aptevo Therapeutics quarterly gross profit
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2019 | 2019-12-31 | $2.9M | $1.0M | +53.66% |
| Q3 2019 | 2019-09-30 | $5.1M | $1.7M | +49.16% |
| Q2 2019 | 2019-06-30 | $1.4M | −$2.9M | −67.96% |
| Q1 2019 | 2019-03-31 | $3.2M | $885,000 | +38.65% |
| Q4 2018 | 2018-12-31 | $1.9M | −$4.2M | −68.94% |
| Q3 2018 | 2018-09-30 | $3.4M | −$913,000 | −21.23% |
| Q2 2018 | 2018-06-30 | $4.3M | $6.7M | — |
| Q1 2018 | 2018-03-31 | $2.3M | $636,000 | +38.45% |
| Q4 2017 | 2017-12-31 | $6.1M | $15.4M | — |
| Q3 2017 | 2017-09-30 | $4.3M | $5.6M | — |
| Q2 2017 | 2017-06-30 | −$2.4M | −$6.0M | — |
| Q1 2017 | 2017-03-31 | $1.7M | −$2.9M | −63.56% |
| Q4 2016 | 2016-12-31 | −$9.4M | — | — |
| Q3 2016 | 2016-09-30 | −$1.3M | −$4.3M | — |
| Q2 2016 | 2016-06-30 | $3.6M | $998,000 | +37.65% |
| Q1 2016 | 2016-03-31 | $4.5M | — | — |
| Q3 2015 | 2015-09-30 | $3.0M | — | — |
| Q2 2015 | 2015-06-30 | $2.7M | — | — |
Aptevo Therapeutics gross profit trends
Between the periods ended 2015-12-31 and 2019-12-31, Aptevo Therapeutics's gross profit decreased from $16.7M to $12.5M, a change of −$4.2M. The latest reported quarter, Q4 2019, shows $2.9M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aptevo Therapeutics source filings ↗